Mr. Fenaux joined Vertex in 2018 as the Senior Vice President of International Commercial Operations. He is responsible for the company’s international commercial activities outside of the U.S. and Canada, which include overseeing offices and operations across Europe, Australia and Latin America.
Mr. Fenaux has more than two decades of pharmaceutical industry experience. Prior to joining Vertex, he spent 12 years at Bristol-Myers Squibb where he held multiple international senior leadership positions of increasing responsibility, including Senior Vice President, Head of Intercontinental Region, Head of U.S. Specialty Care, Head of U.S. Commercial Virology and Transplant, Vice President and General Manager Benelux and Vice President, Global Commercialization Oncology. Prior to joining Bristol-Myers Squibb, Mr. Fenaux held positions of increasing responsibility at Eli Lilly, AstraZeneca and GSK.
Mr. Fenaux is the Chairman of the Local American Pharma Trade Working Group (LAWG) in Belgium and a board member of the Belgian Pharma association (Pharma.be) and Amcham (American Chamber). He holds a Master of Science degree in Biochemistry and an Advanced Master in Marketing Management from ESSEC Business School, in addition to having completed the General Management program at The European Centre for Executive Development (CEDEP) and graduating from the C-Suite Harvard Business School Advanced Management Program.